Catherine Berry
Impact in
-
- Allergic Rhinitis and Sensitization
-
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Eicosanoids and Hypertension Pharmacology 4
-
- Blood Coagulation and Thrombosis Mechanisms 6
- Co-authors
- J.R.S. HoultCatherine LunvenSusan H. PeersValérie LecouturierStephen E. O'ConnorPhilip K. MooreR. GriffithsVincent Pavot
- Journals
- British Journal of Pharmacology (5 papers)Biochemical Pharmacology (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Nature Communications (2 papers)Vaccine (2 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Catherine Berry
24 papers receiving 256 citations
Peers
Comparison fields: 5 of 62
- Immunology and Allergy 25
- Biochemistry 27
- Pharmacology 55
- Infectious Diseases 59
- Hematology 31
Countries citing papers authored by Catherine Berry
This map shows the geographic impact of Catherine Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Berry more than expected).
Fields of papers citing papers by Catherine Berry
This network shows the impact of papers produced by Catherine Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Berry. The network helps show where Catherine Berry may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Catherine Berry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 12 | |
| 3 | 2022 | 25 | |
| 4 | 2020 | 14 | |
| 5 | 2019 | 11 | |
| 6 | 2018 | 4 | |
| 7 | 2003 | 18 | |
| 8 | 2000 | 11 | |
| 9 | 2000 | 4 | |
| 10 | 2000 | 6 | |
| 11 | 1998 | 21 | |
| 12 | 1996 | 9 | |
| 13 | 1992 | 9 | |
| 14 | 1990 | 8 | |
| 15 | 1988 | 13 | |
| 16 | 1986 | 2 | |
| 17 | 1985 | 14 | |
| 18 | Gossypol is a potent inhibitor of the NAD+-dependent dehydrogenase responsible for the inactivation of prostaglandins. | 1985 | 4 |
| 19 | 1983 | 30 | |
| 20 | 1983 | 10 |
About Catherine Berry
Catherine Berry is a scholar working on Biochemistry, Hematology, Pharmacology, Infectious Diseases and Animal Science and Zoology, having authored 24 papers that have together received 270 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Eicosanoids and Hypertension Pharmacology (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Mosquito-borne diseases and control (3 papers), COVID-19 Clinical Research Studies (3 papers), Animal Virus Infections Studies (3 papers) and Viral Infections and Vectors (3 papers). The work is most often cited by research in Immunology and Allergy (25 citations), Biochemistry (27 citations), Pharmacology (55 citations), Infectious Diseases (59 citations) and Hematology (31 citations). Catherine Berry has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include J.R.S. Hoult, Catherine Lunven, Susan H. Peers, Valérie Lecouturier, Stephen E. O'Connor, Philip K. Moore, R. Griffiths, Vincent Pavot, Jane Phillips and D Duval. Their work appears in journals such as British Journal of Pharmacology, Biochemical Pharmacology, Journal of Pharmacology and Experimental Therapeutics, Nature Communications and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.